Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Kynurenines: from the perspective of major psychiatric disorders.

Myint AM.

FEBS J. 2012 Apr;279(8):1375-85. doi: 10.1111/j.1742-4658.2012.08551.x. Epub 2012 Mar 27. Review.

2.

The role of the kynurenine metabolism in major depression.

Myint AM, Schwarz MJ, Müller N.

J Neural Transm (Vienna). 2012 Feb;119(2):245-51. doi: 10.1007/s00702-011-0741-3. Epub 2011 Dec 3. Review.

PMID:
22139324
3.

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A, et al.

Brain. 1992 Oct;115 ( Pt 5):1249-73.

PMID:
1422788
4.
5.

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.

Saito K, Markey SP, Heyes MP.

Neuroscience. 1992 Nov;51(1):25-39.

PMID:
1465184
6.

Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity.

Steiner J, Bogerts B, Sarnyai Z, Walter M, Gos T, Bernstein HG, Myint AM.

World J Biol Psychiatry. 2012 Oct;13(7):482-92. doi: 10.3109/15622975.2011.583941. Epub 2011 Jun 28. Review.

PMID:
21707463
7.

A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.

Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T.

Stress. 2008 May;11(3):198-209. doi: 10.1080/10253890701754068. Review.

PMID:
18465467
8.

COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.

Müller N.

Curr Opin Investig Drugs. 2010 Jan;11(1):31-42. Review.

PMID:
20047157
9.

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

Sas K, Robotka H, Toldi J, Vécsei L.

J Neurol Sci. 2007 Jun 15;257(1-2):221-39. Epub 2007 Apr 25. Review.

PMID:
17462670
10.

Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.

Johansson AS, Owe-Larsson B, Asp L, Kocki T, Adler M, Hetta J, Gardner R, Lundkvist GB, Urbanska EM, Karlsson H.

J Psychiatr Res. 2013 Nov;47(11):1815-23. doi: 10.1016/j.jpsychires.2013.08.008. Epub 2013 Aug 23.

PMID:
24012176
11.

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.

Van Gool AR, Verkerk R, Fekkes D, Bannink M, Sleijfer S, Kruit WH, van der Holt B, Scharpé S, Eggermont AM, Stoter G, Hengeveld MW.

Psychiatry Clin Neurosci. 2008 Oct;62(5):597-602. doi: 10.1111/j.1440-1819.2008.01854.x.

12.

Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.

Miller CL, Llenos IC, Cwik M, Walkup J, Weis S.

Neurochem Int. 2008 May;52(6):1297-303. doi: 10.1016/j.neuint.2008.01.013. Epub 2008 Feb 2.

PMID:
18328600
13.

Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.

Myint AM, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:304-13. doi: 10.1016/j.pnpbp.2013.08.008. Epub 2013 Oct 31. Review.

PMID:
24184687
14.

Serum kynurenic acid is reduced in affective psychosis.

Wurfel BE, Drevets WC, Bliss SA, McMillin JR, Suzuki H, Ford BN, Morris HM, Teague TK, Dantzer R, Savitz JB.

Transl Psychiatry. 2017 May 2;7(5):e1115. doi: 10.1038/tp.2017.88.

15.

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.

Myint AM, Schwarz MJ, Verkerk R, Mueller HH, Zach J, Scharpé S, Steinbusch HW, Leonard BE, Kim YK.

Brain Behav Immun. 2011 Nov;25(8):1576-81. doi: 10.1016/j.bbi.2011.05.005. Epub 2011 May 17.

PMID:
21620952
16.

Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder.

Meador-Woodruff JH, Hogg AJ Jr, Smith RE.

Brain Res Bull. 2001 Jul 15;55(5):631-40.

PMID:
11576760
17.

Does escitalopram reduce neurotoxicity in major depression?

Halaris A, Myint AM, Savant V, Meresh E, Lim E, Guillemin G, Hoppensteadt D, Fareed J, Sinacore J.

J Psychiatr Res. 2015 Jul-Aug;66-67:118-26. doi: 10.1016/j.jpsychires.2015.04.026. Epub 2015 May 12.

PMID:
26009299
19.
20.

Supplemental Content

Support Center